Literature DB >> 1719435

On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.

K Schrör1, S Förster, I Woditsch.   

Abstract

This study determines the release of nitric oxide (NO) from the coronary circulation of Langendorff hearts of rabbits, subsequent to administration of glyceryl trinitrate (GTN) and SIN-1. NO was measured on-line in the coronary effluent by the oxyhaemoglobin technique. Infusion of either GTN (10-40 mumoles/l) or SIN-1 (0.1-2.3 mumoles/l) into the coronary inflow resulted in a concentration-dependent NO release into the coronary effluent and a decrease in the coronary vascular resistance. NO generation from SIN-1 was identical with and without passage of the coronary circulation whereas NO generation from GTN was only detected after passage of the coronary vascular bed. NO generation by both substances was in the same range as endogenous NO release by two endothelium-dependent vasodilators, bradykinin (0.05 mumoles/l) and substance P (0.05 mumoles/l). Oxyhaemoglobin used for the assay of NO, inhibited the relaxation by SIN-1, but did not reduce vessel relaxations induced by GTN or iloprost, a stable prostacyclin analogue. Removal of the coronary endothelium by trypsin or pretreatment with L-NG-Monomethylarginine (30 mumoles/l) did neither affect NO release from GTN and SIN-1 nor the vasodilatory effect of both substances. These data are the first to directly demonstrate endothelium-independent NO release from organic nitrates during passage of an intact organ circulation. They additionally suggest a subendothelial site of metabolic NO formation from GTN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719435     DOI: 10.1007/bf00167225

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.

Authors:  A Mülsch; R Busse; I Winter; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

2.  Perfused rabbit heart: endothelium-derived relaxing factor in coronary arteries.

Authors:  M Saeed; J Schmidli; M Metz; R J Bing
Journal:  J Cardiovasc Pharmacol       Date:  1986 Mar-Apr       Impact factor: 3.105

Review 3.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

Review 4.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.

Authors:  R M Rapoport; F Murad
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983

5.  Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide.

Authors:  K S Wood; G M Buga; R E Byrns; L J Ignarro
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

6.  Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

7.  Nitric oxide release from the isolated guinea pig heart.

Authors:  M Kelm; J Schrader
Journal:  Eur J Pharmacol       Date:  1988-10-18       Impact factor: 4.432

8.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

9.  Human red blood cells inhibit endothelium-derived relaxing factor (EDRF) activity.

Authors:  H G Evans; H C Ryley; I Hallett; M J Lewis
Journal:  Eur J Pharmacol       Date:  1989-04-25       Impact factor: 4.432

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more
  7 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

3.  Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP.

Authors:  T Csont; Z Szilvássy; F Fülöp; S Nedeianu; T Páli; A Tosaki; L Dux; P Ferdinandy
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits.

Authors:  I Woditsch; K Schrör
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.

Authors:  A Mülsch; A Bara; P Mordvintcev; A Vanin; R Busse
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.

Authors:  M Civelli; M Giossi; P Caruso; R Razzetti; M Bergamaschi; S Bongrani; A Gasco
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Authors:  Bobby Nossaman; Edward Pankey; Philip Kadowitz
Journal:  Crit Care Res Pract       Date:  2012-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.